Page 3 - Nova Plc News Today

In a report released yesterday, Matt Miksic from Barclays maintained a Hold rating on LivaNova (LIVN – Research Report), with a price targ...

Mizuho began coverage on shares of LivaNova (NASDAQ:LIVN – Get Rating) in a research report issued on Thursday, The Fly reports. The firm set a “neutral” rating on the stock. Several other research analysts also recently weighed in on LIVN. Barclays cut their price target on LivaNova from $62.00 to $45.00 in a report on […]

LivaNova PLC (NASDAQ:LIVN – Get Rating) has earned an average rating of “Moderate Buy” from the seven brokerages that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month price objective among brokers that […]

VELA Investment Management LLC grew its stake in LivaNova PLC (NASDAQ:LIVN – Get Rating) by 4.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,187 shares of the company’s stock after purchasing an additional 514 shares during the quarter. VELA Investment Management […]

VELA Investment Management LLC increased its holdings in LivaNova PLC (NASDAQ:LIVN – Get Rating) by 4.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,187 shares of the company’s stock after buying an additional 514 shares during the period. VELA Investment Management […]

LivaNova PLC (NASDAQ:LIVN – Get Rating) was the recipient of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 1,940,000 shares, a decline of 13.0% from the February 28th total of 2,230,000 shares. Based on an average daily trading volume, of 523,900 shares, the […]

Putnam Investments LLC lessened its holdings in LivaNova PLC (NASDAQ:LIVN – Get Rating) by 1.8% in the 3rd quarter, Holdings Channel reports. The firm owned 35,404 shares of the company’s stock after selling 644 shares during the quarter. Putnam Investments LLC’s holdings in LivaNova were worth $1,798,000 as of its most recent SEC filing. Other […]

/PRNewswire/ -- The "Neuromodulation Devices Global Market- Forecast To 2029" report has been added to ResearchAndMarkets.coms offering. The neuromodulation...

/PRNewswire/ -- The thoracic catheters market size is expected to increase by USD 154.02 mn from 2021 to 2026. The growth momentum of the market will...

Markets Needham analyst Michael Matson maintained a Hold rating on LivaNova (LIVN – Research Report) today. The company’s shares closed last Wednesday at $87.05. According to TipRanks.com, Matson is a 5-star analyst with an average return of 17.3% and a 72.0% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings. LivaNova has an analyst consensus of Moderate Buy, with a price target ...